Pulse Medical (PLSE): Enterprise Value to EBITDA Ratio
Risks for Pulse Biosciences, Inc. (PLSE) are tied to the commercialization pace of Nano-Pulse systems and liquidity costs. This EV/EBITDA chart, provided by GURU.Markets, demonstrates these fluctuations, where the 0.00 level captures the latest values. Stability is supported by outsourced manufacturing and cloud data storage, while high barriers to entry are guaranteed by unique patents for nanosecond pulses.
Comprehensive metric breakdowns and analytics for pulsebiosciences.com (PLSE)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Pulse Biosciences, Inc.|PLSE - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Pulse Biosciences|PLSE - Company Total Debt|Debts to Book Capitalization Pulse Medical|PLSE - Long-Term Debt|Company Short-Term Debts Pulse Biosciences|Quick Ratio pulsebiosciences.com
- financial results and valuation multiples details:
PLSE - Net Financial Result|Projected Future Earnings Pulse Biosciences, Inc.|PLSE - Price to Earnings Ratio|Forward P/E Multiple Pulse Biosciences, Inc.|PLSE - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pulse Medical|PLSE - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Pulse Biosciences|PLSE - Earnings per share for the trailing year|Quarterly EPS earnings growth pulsebiosciences.com|PLSE - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Pulse Biosciences, Inc.
Analysis of all company metrics:Pulse Corp PLSE
To assess the credit quality of Pulse Biosciences, Inc. (PLSE), the analyst utilizes an EV/EBITDA multiple chart, which relates the total enterprise value to operating profit before depreciation and amortization. Given the costs associated with specialized logistics for high-precision equipment, this indicator strips the valuation of debt burdens and tax distortions, allowing the investor to determine a fair premium for the scalability of bioelectric systems.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio InMode MD (INMD)|Enterprise Value to EBITDA Ratio PMI (Picard Medical Inc)|SRDX (surmodics.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Senseonics Holdings Inc SENS|NPCE - Enterprise Value to EBITDA Ratio|Tactile Systems Technology Inc. - EV/EBITDA Multiple|Company Value to EBITDA SANUWAVE Health Inc|OM: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ELMD|LNSR (LENSAR) - EV/EBITDA Multiple|AVITA Medical Inc. (RCEL) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple PROF|Enterprise Value to EBITDA Ratio bairdmed.com BDMD|EV/EBITDA Multiple EDAP (EDAP TMS)|EV/EBITDA Multiple Apyx Medical Corp APYX|ICCM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TELA (telabio.com) - Enterprise Value to EBITDA Ratio|CytoSorbents Corporation - Business Value to Operating Income Before Depreciation|SRTS (Sensus Healthcare, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA zynex.com ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore, Inc. (ECOR)|vicarioussurgical.com (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple SeaStar Medical Holding Corp. ICU|IRIDEX Corp. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions INBS|beyondair.net (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BioSig Technologies, Inc. (BSGM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio CUTR (cutera.com)|Enterprise Value to EBITDA Ratio KNW|EV/EBITDA Multiple Inari Medical Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nevro Corporation (NVRO)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RSLS (reshapelifesciences.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Silk Road Medical, Inc SILK
